Plasticizers for a biodegradable scaffolding and methods of forming same

US9610387B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9610387-B2
Application numberUS-201615170618-A
CountryUS
Kind codeB2
Filing dateJun 1, 2016
Priority dateJun 13, 2014
Publication dateApr 4, 2017
Grant dateApr 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of making polymeric devices, such as stents, with one or more modifications such as addition of plasticizers, to improve processing, and the devices made by these methods.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of fabricating a medical device, the method comprising: processing a polymer to form a medical device or a polymer construct, the processing occurring at a high temperature, the high temperature being above the melting temperature of the polymer, if the polymer exhibits a melting temperature above 35° C., or if the polymer does not exhibit a melting temperature above 35° C., at a temperature higher than 100° C. above the glass transition temperature (Tg) of the polymer, or higher than 75° C., if 75° C. is greater than 100° C. above the Tg of the polymer; adding a plasticizer to the polymer prior to, during, or both prior to and during the processing of the polymer; wherein the plasticizer is different from any solvent used in production of the polymer; removing at least 75 weight % of the plasticizer from the processed polymer, the removal comprising heating the processed polymer to and maintaining the processed polymer at a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer; optionally executing one or more additional processing operations on the medical device or on the polymer construct; wherein the polymer has a number average molecular weight as measured by GPC using polystyrene standards of at least 250,000 g/mole, but not more than 3,000,000 g/mole, the polymer has a weight average molecular weight of at least 300,000 g/mole but not more than 4,500,000 g/mole, an inherent viscosity of at least 3.3 dl/g, but not more than 15 dl/g, or a combination thereof; wherein the polymer that is processed optionally comprises another material in addition to the plasticizer; and wherein if the polymer construct is formed, at least one additional processing operation is executed to form a medical device from the polymer construct. 2. The method of claim 1 , wherein the plasticizer is added at a weight ratio of plasticizer to polymer of about 1/1000 to 1/10. 3. The method of claim 1 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof. 4. The method of claim 1 , wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising heating the polymer to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer. 5. The method of claim 1 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof to form the polymer construct, the polymer construct being a polymer tube, and wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising axial expansion of the polymer tube, radial expansion of the polymer tube, or a combination of radial and axial expansion of the polymer tube after the polymer tube has been heated to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer of the polymer tube. 6. The method of claim 5 , additionally comprising forming a pattern in the tube to form the medical device. 7. The method of claim 1 , wherein the plasticizer is selected from the group consisting of citrate ester, phthalate esters, C1 to C16 esters of α-hydroxy acids, oligomers of up to 10 units of α-hydroxy acids, C1 to C16 esters of these oligomers of α-hydroxy acids, and combinations thereof. 8. The method of claim 1 , wherein the removal of at least 90 weight % of the plasticizer is executed prior to the medical device being packaged. 9. The method of claim 8 , wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising heating the polymer to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer; and wherein the plasticizer is removed during, after, or both during and after the at least one additional processing operation. 10. The method of claim 9 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof to form a polymer tube, and wherein the at least one additional processing operation further comprises axial expansion of the polymer tube, radial expansion of the polymer tube, or a combination of radial and axial expansion of the polymer tube after the polymer tube has been heated to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer of the polymer tube. 11. The method of claim 10 , additionally comprising forming a pattern in the tube to form the medical device. 12. The method of claim 1 , wherein the heating and maintaining occurs at a pressure below 200 Torr. 13. The method of claim 1 , wherein the heating and maintaining occurs in an environment with a humidity of at least 40% rh and not more than 99% rh. 14. The method of claim 1 , wherein during the heating and maintaining, the polymer is exposed to solvent vapor of at least 20 Torr partial pressure wherein the solvent is a good solvent for the plasticizer. 15. The method of claim 14 , wherein the solvent at least partially plasticizes the polymer. 16. The method of claim 14 , wherein the partial pressure of the solvent vapor is at least 200 Torr. 17. The method of claim 14 , wher

Assignees

Inventors

Classifications

  • Polymers of esters · CPC title

  • Thermal after-treatment {(B29C71/0063 and B29C71/0072 take precedence)} · CPC title

  • using liquids, e.g. solvents, swelling agents (spectacle cases, e.g. for cleaning contact lenses A45C11/04; disinfecting or sterilising contact lenses A61L12/00, using liquid substances A61L2/20; cleaning involving the use of liquid in general B08B3/00; for hydrating contact lenses B29D11/00067) · CPC title

  • Annealing · CPC title

  • Heating or cooling · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9610387B2 cover?
Methods of making polymeric devices, such as stents, with one or more modifications such as addition of plasticizers, to improve processing, and the devices made by these methods.
Who is the assignee on this patent?
Abbott Cardiovascular Systems Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/141. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).